Paula Soteropoulos, Director at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 599 shares at $85.47 ($51K) on 2026-05-08, disclosed to the SEC on 2026-05-11.
Scheduled sale ($51k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |